First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Immunicum-teknik i lyckad preklinisk studie

Resultaten publiceras i en vetenskaplig tidskrift.

Vinnova ger stöd till precisionsmedicin – här är projekten som får anslag

Vinnova anslår totalt 323 miljoner kronor i en stor satsning på precisionsmedicin.

Less scars with new product

A new Swedish product for post surgical scar formation enters clinical development.

Next generation sequencer in an accessible format

The GS Junior System is a new benchtop-sized next generation sequencing platform.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Grundare och känd forskare lämnar Alligator Bioscience

Alligator Bioscience grundare Carl Borrebaeck lämnar bolaget i protest mot valberedningens förslag på ny styrelse. ”Företaget dräneras på immunonkologisk kompetens”, säger han.

Follicum tar USA-patent

Lundaföretaget Follicums peptider mot diabetes patenteras i USA.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Avtalet med Almirall sägs upp

Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Tio minuters trädgårdsarbete räcker

Så lite som tio minuters motion per vecka ser ut att minska risken för hjärtdöd, enligt en kinesisk observationsstudie.

Forskare har hittat sätt att rensa kroppen på triglycerider

Två amerikanska forskare har hittat ett sätt att i laboratoriet framställa ett mänskligt protein, kallad APOA 5, som normalt sätt produceras i levern.

Stort intresse för New Horizons

Just nu pågår livesändningen av Life Science Swedens event New Horizons in Biologics & Bioprocessing – och intresset är rekordstort.

LEO Pharma - International Clinical Trial Manager

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...

Age essential when testing drugs

Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...

Hennes budskap på life science-konferensen: "Vi är i pole position"

Svensk life science har stått sig väl under pandemin, konstaterade en panel vid måndagens stora nationella life science-konferens. Särskilt hissades utvecklinge...